Emeritus Professor Takashi Muramatsu is the co-discoverer of midkine. He has authored more than 200 peer-reviewed publications on the role of this exciting novel target during the past 25 years. Professor Muramatsu is inventor on a number of Cellmid’s patents and he continues to actively contribute to the field of midkine research.
A distinguished scientist, Professor Muramatsu graduated from The University of Tokyo in 1963 and received his PhD from The University of Tokyo in 1968. He was Research Fellow, Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York (1968-72), before going on to become Assistant Professor (1972-73) and then Associate Professor (1973-80) in the Department of Biochemistry at Kobe University School of Medicine. In 1975 he received the Young Investigator’s Award from Japanese Biochemical Society for research into glycosidases acting on glycoconjugates. During this period Professor Muramatsu was also Visiting Scientist within the Department of Molecular Biology, Pasteur Institute, Paris (1977-78).
In 1980 he was appointed to the position of Professor of the Department of Biochemistry at Kagoshima University Faculty of Medicine where he continued until 1993. He then became Professor, Department of Biochemistry, Nagoya University School of Medicine (1993-2000). In 2000 he was appointed Professor and Chairman, Department of Biological Chemistry, Nagoya University Graduate School of Medicine, a role he fulfilled until 2004.
In 2002 Professor Muramatsu was awarded the prestigious Chunichi Cultural Prize for the ‘Discovery of a cell growth factor, midkine’. He served as Associate Editor, Glycobiology (1999-2007) and President, Japanese Biochemical Society (2002-03)
Since 2004 he has been Professor in the Department of Health Science, Faculty of Psychological and Physical Science at Aichi Gakuin University, where he remains actively involved in midkine research, as well as being Professor Emeritus, Nagoya University.
Professor Muramatsu brings a wealth of lifelong research and his unparalleled knowledge of midkine to Cellmid.